• Markets
  • icon
  • Companies
MAP · ASX

Microba Life Sciences Limited (ASX:MAP)

AU$0.18

 0.0 (0.0%)
ASX:Live
14/06/2024 03:33:47 PM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

MAP Overview

MAP Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About MAP

Website

N/A

Telephone

Address

Description

Microba Life Sciences Ltd. analyzes the microbiome to discover novel therapeutics and develop new diagnostic tools. Its therapeutic discovery platform,analysis platform and discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The firm offers microbiome testing services via distribution partners, and is working on microbial cell therapies for inflammatory bowel disease, cancer immunotherapy and autoimmune disease. The company was founded by Gene Tyson and Philip Hugenholtz in 2017 and is headquartered in Brisbane, Australia.

MAP Price Chart

Key Stats

Market Cap

AU$78.37M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.15 - 0.42

Trade Value (12mth)

AU$15,350.00

1 week

-5.41%

1 month

-2.78%

YTD

-2.78%

1 year

-33.77%

All time high

0.4246880114078522

Key Fundamentals

EPS 3 yr Growth

57.400%

EBITDA Margin

-342.90%

Operating Cashflow

-$12m

Free Cash Flow Return

-34.00%

ROIC

-34.80%

Interest Coverage

-307.60

Quick Ratio

5.20

Other Data

Shares on Issue (Fully Dilluted)

372m

HALO Sector

Next Company Report Date

22-Oct-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.53

MAP Announcements

Latest Announcements

Date Announcements

03 June 24

Notification of cessation of securities - MAP

×

Notification of cessation of securities - MAP

23 April 24

Q3 FY24 Quarterly Activities Report & Appendix 4C

×

Q3 FY24 Quarterly Activities Report & Appendix 4C

23 April 24

Q3 FY24 Quarterly Investor Presentation

×

Q3 FY24 Quarterly Investor Presentation

18 April 24

Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar

×

Details of Q3 FY24 Quarterly Report, Appendix 4C & Webinar

16 April 24

Microba Launches Investor Hub for Investor Engagement

×

Microba Launches Investor Hub for Investor Engagement

10 April 24

Notification of cessation of securities - MAP

×

Notification of cessation of securities - MAP

10 April 24

Microba receives $6.08 million R&D Tax Incentive Refund

×

Microba receives $6.08 million R&D Tax Incentive Refund

05 April 24

Application for quotation of securities - MAP

×

Application for quotation of securities - MAP

05 April 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

25 March 24

Release of Restricted Securities

×

Release of Restricted Securities

13 March 24

MetaPanel Diagnostic Test Launched with Sonic Healthcare

×

MetaPanel Diagnostic Test Launched with Sonic Healthcare

13 March 24

MetaPanel Launch Investor Presentation

×

MetaPanel Launch Investor Presentation

04 March 24

Change in substantial holding

×

Change in substantial holding

28 February 24

Appendix 4D & FY24 Interim Report

×

Appendix 4D & FY24 Interim Report

26 February 24

Change in substantial holding

×

Change in substantial holding

30 January 24

Q2 FY24 Quarterly Activities Report & Appendix 4C

×

Q2 FY24 Quarterly Activities Report & Appendix 4C

30 January 24

Q2 FY24 Quarterly Investor Presentation

×

Q2 FY24 Quarterly Investor Presentation

29 January 24

Details of Q2 FY24 Quarterly Report, Appendix 4C & Webinar

×

Details of Q2 FY24 Quarterly Report, Appendix 4C & Webinar

25 January 24

Notification of cessation of securities - MAP

×

Notification of cessation of securities - MAP

19 January 24

Release of Restricted Securities

×

Release of Restricted Securities

29 December 23

Change of Director's Interest Notice - Jacqueline Fernley

×

Change of Director's Interest Notice - Jacqueline Fernley

29 December 23

Notification regarding unquoted securities - MAP

×

Notification regarding unquoted securities - MAP

07 December 23

Successful IBD Phase I Clinical Trial

×

Successful IBD Phase I Clinical Trial

06 December 23

Completion of Acquisition of Invivo Clinical Limited

×

Completion of Acquisition of Invivo Clinical Limited

06 December 23

Application for quotation of securities - MAP

×

Application for quotation of securities - MAP

MAP Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.04 -0.04 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.04 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.2 -52.6 8.9 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.04 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.04 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -15.0 -73.0 20.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -22.0 -13.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.05 0.12 0.11 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.05 0.12 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 109.0 135.7 -17.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 274 274 333 Lock Lock Lock
Basic m Lock Lock Lock Lock 274 274 333 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 4 5 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.3 25.6 15.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 9 13 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -5 -8 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -30.9 -46.1 12.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -142.1 -165.3 -125.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 242 265 225 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -8 -15 -19 Lock Lock Lock
     Growth % Lock Lock Lock Lock -32.3 -76.3 -26.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -223.8 -314.1 -342.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -10 -16 -20 Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.2 -70.0 -24.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -256.4 -347.1 -373.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -8 -11 -19 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -6 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -8 -11 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -13.1 -52.5 -10.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -201.6 -244.6 -233.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -7 -10 -12 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 2 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -2 -3 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 14 29 17 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -7 -12 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -58.6 -62.7 -7.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2.0 -2.6 -2.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 13 31 32 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 18 39 47 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -13 -29 -31 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 3 6 8 Lock Lock Lock
Equity $m Lock Lock Lock Lock 15 34 39 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 15 34 39 Lock Lock Lock
     Growth % Lock Lock Lock Lock 88.7 126.8 14.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -40.7 -29.1 -27.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.4 -34.2 -32.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -81.5 -65.0 -54.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -65.6 -46.8 -34.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -62.6 -42.6 -34.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -356.1 -266.4 -307.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.5 2.0 1.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -85.4 -87.8 -80.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.8 6.8 5.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.7 6.7 5.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 80.3 86.0 77.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -214.1 -198.5 -158.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.3 1.8 1.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 21.2 28.5 24.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.3 0.2 0.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.5 17.3 55.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -201.6 -244.4 -346.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -40.7 -29.0 -40.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -40.7 -29.1 -27.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.4 -34.2 -32.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -34.2 -32.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 17.2 12.8 15.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 111.1 197.4 358.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 128.4 210.3 373.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 14.8 17.3 55.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 113.6 192.9 318.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.53%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

MAP Shortsell

Frequently Asked Questions

The current share price of Microba Life Sciences Limited (MAP:ASX) is AU$0.18.
The 52-week high share price for Microba Life Sciences Limited (MAP:ASX) is AU$0.42.
The 52-week low share price for Microba Life Sciences Limited (MAP:ASX)? is AU$0.15.
Microba Life Sciences Limited (MAP:ASX) does not pay a dividend.
Microba Life Sciences Limited (MAP:ASX) does not pay a dividend.
Microba Life Sciences Limited (MAP:ASX) has a franking level of 0.0%.
Microba Life Sciences Limited (MAP:ASX) is classified in the Healthcare.
The current P/E ratio for Microba Life Sciences Limited (MAP:ASX) is .